| Domain-interface dynamics of CFTR revealed by stabilizing nanobodies M Sigoillot, M Overtus, M Grodecka, D Scholl, A Garcia-Pino, ... Nature communications 10 (1), 2636, 2019 | 28 | 2019 |
| A topological switch in CFTR modulates channel activity and sensitivity to unfolding D Scholl, M Sigoillot, M Overtus, RC Martinez, C Martens, Y Wang, ... Nature Chemical Biology 17 (9), 989-997, 2021 | 14 | 2021 |
| Assessment of CFTR thermal stability before and after purification L He, L Aleksandrov, T Jensen, M Sigoillot, J Kousouros, L Cui, M Overtus, ... Pediatric Pulmonology 51, 197-197, 2016 | 2 | 2016 |
| A Cell-Permeable Nanobody to Restore F508del Cystic Fibrosis Transmembrane Conductance Regulator Activity L Franz, T Rubil, A Balazs, M Overtus, K Kemnitz-Hassanin, C Govaerts, ... bioRxiv, 2024.04. 26.591242, 2024 | | 2024 |
| STRUCTURAL STUDIES OF SECONDAIRY MULTIDRUGS TRANSPORTERS L Jodaitis, A Hutchin, F Jaumaux, V Debruycker, M Overtus, A Roth, ... | | 2021 |
| A Topological Switch in the Cystic Fibrosis Transmembrane Conductance Regulator Modulates Channel Activity and Sensitivity to Disease-Causing Mutation D Scholl, M Sigoillot, M Overtus, R Colomer, C Martens, Y Wang, ... | | 2020 |
| Cystic fibrosis transmembrane conductance regulator stabilizing agents J Steyaert, E Pardon, T Laeremans, C Govaerts, M Grodecka, M Sigoillot, ... | | 2020 |
| A Topological Switch Enables Misfolding of the Cystic Fibrosis Transmembrane Conductance Regulator D Scholl, M Sigoillot, M Overtus, RC Martinez, C Martens, Y Wang, ... bioRxiv, 2020.07. 09.195099, 2020 | | 2020 |
| DEVELOPMENT OF NANOBODIES AGAINST CFTR M Sigoillot, M Grodecka, D Franois, M Overtus, L He, T Laeremans, ... Pediatric Pulmonology 50, 218-218, 2015 | | 2015 |
